7-<3-(3-Hydroxyoctyl)-4-oxo-2-thiazolidinyl>-heptansaeure | 64250-24-4

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 7-<3-(3-Hydroxyoctyl)-4-oxo-2-thiazolidinyl>-heptansaeure
• 英文别名: 3-(3-hydroxyoctyl)-2-(carboxyheptyl)-1,3-thiazolidin-4-one；7-[3-(3-hydroxyoctyl)-4-oxo-2-thiazolidinyl]heptanoic acid；7-[3-(3-hydroxyoctyl)-4-oxo-1,3-thiazolidin-2-yl]heptanoic acid
• CAS: 64250-24-4
• 化学式: C₁₈H₃₃NO₄S
• 分子量: 359.53
• InChiKey: MAKBTMYLUUUASJ-UHFFFAOYSA-N

物化性质

• 沸点：
  579.9±45.0 °C(Predicted)
• 密度：
  1.106±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  24
• 可旋转键数：
  14
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  103
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  7-<3-(3-Hydroxyoctyl)-4-oxo-2-thiazolidinyl>-heptansaeure 在 草酰氯 、 N,N-二甲基甲酰胺 作用下， 以 二氯甲烷 为溶剂， 反应 0.5h， 生成
  参考文献：
  名称：

  2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use

  摘要：

  本文披露了2-脱羧-2-膦基前列腺素衍生物。这些衍生物包括一个改性的α链和一个与环结构相结合的Ω链。改性的α链具有2-脱羧-2-膦基基团。这些衍生物可用于治疗各种药物和化妆品状况。

  公开号：

  US06894175B1
• 作为产物：
  描述：

  正戊基溴化镁 在 sodium hydroxide 、 sodium hydride 、 sodium iodide 作用下， 以 甲醇 、 乙醚 、 丙酮 为溶剂， 反应 27.0h， 生成 7-<3-(3-Hydroxyoctyl)-4-oxo-2-thiazolidinyl>-heptansaeure
  参考文献：
  名称：

  Prostaglandin isosteres. 2. Chain-modified thiazolidinone prostaglandin analogs as renal vasodilators

  摘要：

  Chain modification of a thiazolidinone prostaglandin isostere has led to the production of 4-[3-[3-[2-(1-hydroxycyclohexyl)ethyl]-4-oxo-2-thiazolidinyl]propyl] benzoic acid (5b) which at 1 mg/kg po in the conscious dog causes a 70% increase in renal blood flow over control values with a duration of action exceeding 5 h. Preliminary testing indicates that 5b has a relatively specific action on the vasculature of the kidney. The enantiomers of 5b have been separated and the renal vasodilatory activity has been found to be entirely a property of the R-(+) enantiomer.

  DOI：

  10.1021/jm00357a006

文献信息

• Novel analogs of prostaglandins with 4-oxo-thiazolidinyl nucleus and
  申请人：Merck & Co., Inc.

  公开号：US04022794A1

  公开（公告）日：1977-05-10

  This invention relates to novel 9-thia-, 9-oxothia-, and 9-dioxothia-11-oxo-12-azaprostanoic acid compounds, salts, and derivatives thereof and also to processes for the preparation of such compounds. These compounds have prostaglandin-like biological activity and are particularly useful as renal vasodilators, as platelet aggregation inhibitors, and for the treatment of certain autoimmune diseases.

  本发明涉及新型9-硫代、9-氧代硫代和9-二氧代硫代-11-氧代-12-氮杂前列腺酸化合物、盐及其衍生物，以及制备这样的化合物的方法。这些化合物具有类似前列腺素的生物活性，特别适用于作为肾脏血管扩张剂、血小板聚集抑制剂以及治疗某些自身免疫性疾病。
• US4022794A
  申请人：——

  公开号：US4022794A

  公开（公告）日：1977-05-10
• Prostaglandin isosteres. 2. Chain-modified thiazolidinone prostaglandin analogs as renal vasodilators
  作者：John B. Bicking、Mark G. Bock、Edward J. Cragoe、Robert M. DiPardo、Norman Gould、Wilbur J. Holtz、T. J. Lee、Charles M. Robb、Robert L. Smith

  DOI：10.1021/jm00357a006

  日期：1983.3

  Chain modification of a thiazolidinone prostaglandin isostere has led to the production of 4-[3-[3-[2-(1-hydroxycyclohexyl)ethyl]-4-oxo-2-thiazolidinyl]propyl] benzoic acid (5b) which at 1 mg/kg po in the conscious dog causes a 70% increase in renal blood flow over control values with a duration of action exceeding 5 h. Preliminary testing indicates that 5b has a relatively specific action on the vasculature of the kidney. The enantiomers of 5b have been separated and the renal vasodilatory activity has been found to be entirely a property of the R-(+) enantiomer.
• 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
  申请人：DeLong Mitchell Anthony

  公开号：US06894175B1

  公开（公告）日：2005-05-17

  2-Decarboxy-2-phosphinico prostaglandin derivatives are disclosed. These derivatives comprise a modified α-chain and an Ω-chain bonded to a ring structure. The modified α-chain has a 2-decarboxy-2-phosphinico group. The derivatives can be used to treat a variety of pharmaceutical and cosmetic conditions.

  本文披露了2-脱羧-2-膦基前列腺素衍生物。这些衍生物包括一个改性的α链和一个与环结构相结合的Ω链。改性的α链具有2-脱羧-2-膦基基团。这些衍生物可用于治疗各种药物和化妆品状况。